Skip to Content

FDA Alerts Archive

Get alerts by email or subscribe to our news feeds.

News Archive for August 2003

August 12, 2003

Pyrazinamide plus Rifampin for Treatment of Latent Tuberculosis Infection (LTBI)
Rifampin plus Pyrazinamide for Treatment of Latent Tuberculosis Infection (LTBI)

August 15, 2003

August 20, 2003

Reyataz (atazanavir sulfate)

FDA Alerts Archive

More News Resources

Sign In or Register

FDA Consumer Updates

More FDA updates...

Recently Approved

Nymalize Nymalize (nimodipine) is a calcium channel blocker indicated to improve neurological outcome following...
Breo Ellipta Breo Ellipta (fluticasone and vilanterol) is a once-a-day inhaled corticosteroid / long-acting beta2 agonist...
Liptruzet Liptruzet (atorvastatin and ezetimibe) is a statin (HMG-CoA reductase inhibitor) and cholesterol absorption...
Procysbi Procysbi (cysteamine bitartrate) is a cystine depleting agent indicated for the treatment of nephropathic...
Kcentra

More...

Get Updates by Email

Email me:

Support

About Drugs.com

Your Privacy

Follow: Google+ Facebook Twitter YouTube

Drugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment.

Data sources include Micromedex™ (updated May 16th, 2013), Cerner Multum™ (updated May 20th, 2013), Wolters Kluwer™ (updated Apr 30th, 2013) and others. To view content sources and attributions, refer to our editorial policy.

We comply with the HONcode standard for trustworthy health information.
Verify here

Terms of Use · Privacy Policy

FDA Alerts Archive

News Archive for August 2003

August 12, 2003

August 15, 2003

August 20, 2003

FDA Alerts Archive

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

More News Resources

Recommended